You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Octave reported third-quarter insurance distribution revenue growth of 35%, driven by 23% organic growth, and expects to exceed its $45 million adjusted EBITDA guidance for the year.
Octave Specialty Group, Inc. reported nine-month total revenues of $272,508 and net loss of $27,877, compared with $184,319 and $229,418 in 2025.
Octave Specialty Group, Inc. reported third-quarter revenue of $85.3 million, up 28%, and adjusted EBITDA to shareholders of $3.3 million versus $(2.9) million, while the loss attributable to shareholders narrowed to $(13.8) million.
Useful current figures from the complete screener profile.
* Q4 derived as the full year minus Q1 to Q3.
TL;DR. Octave Specialty Group raised consolidated adjusted EBITDA guidance to $45 million (from $40 million) but lowered Everspan adjusted EBITDA guidance to $6 million (from $7.5 million) and slashed full-year adjusted net income per share guidance to $0.15–$0.20 (from $0.50), citing higher acquisition costs at Everspan and revised interest/depreciation/tax/NCI assumptions. Insurance Distribution delivered Q2 organic revenue growth of 44% and nearly fourfold adjusted EBITDA growth year-over-year, while Everspan's combined ratio improved more than 600 bps year-over-year.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Illustrative technical + ownership context — a signal mix, not investment advice.
| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | $36.83M | Six Months Ended June 30, 2026 | — |
| Adjusted EBITDA attributable to shareholders non-GAAP | $23.75M | Six Months Ended June 30, 2026 | — |
| Adjusted EBITDA Margin non-GAAP | 19.7% | Six Months Ended June 30, 2026 | — |
| Adjusted EBITDA margin to shareholders non-GAAP | 6.5% | Three Months Ended June 30, 2026 filing | — |
| Adjusted EBITDA to shareholders non-GAAP | $3.69M | Three Months Ended June 30, 2026 filing | — |
GAAP → non-GAAP reconciliationAdjusted EBITDA 9.11M (non-GAAP)
-5.42M Impact of noncontrolling interest
= Adjusted EBITDA to shareholders 3.69M
|
|||
| Adjusted EBITDA to shareholders per diluted share non-GAAP | $0.08 | Three Months Ended June 30, 2026 | — |
| Adjusted net income (loss) attributable to shareholders non-GAAP | $14.8M | Six Months Ended June 30, 2026 | — |
| Combined Ratio | 100.6% | Three Months Ended June 30, 2026 | — |
| EBITDA non-GAAP | $3.37M | Three Months Ended June 30, 2026 filing | — |
GAAP → non-GAAP reconciliationGAAP Net income (loss) (Continuing Operations) -12.16M
+2.77M Add: Interest expense
+485K Add: Income tax expense (benefit)
+655K Add: Depreciation expense
+11.61M Add: Intangible amortization expense
= EBITDA 3.37M
|
|||
| Expense Ratio | 39.2% | Three Months Ended June 30, 2026 | — |
| Gross premiums written | $95M | second quarter of 2026 | — |
| Insurance Distribution EBITDA | $13.89M | Three Months Ended June 30, 2026 filing | — |
| Insurance Distribution Premiums Placed | $733.5M | Six Months Ended June 30, 2026 | — |
| Loss Ratio | 61.4% | Three Months Ended June 30, 2026 | — |
| Net premiums written | $23M | second quarter of 2026 | — |
| Organic Growth non-GAAP | 44.1% | Three Months Ended June 30, 2026 | — |
| Organic Revenue Growth Rate | 42.9% | Six Months Ended June 30, 2026 | — |
| Premiums placed | 314.37M | Three Months Ended June 30, 2026 | — |
| Retention Ratio | 24.4% | Three Months Ended June 30, 2026 filing | — |
| Specialty P&C Insurance Production | $931.92M | Six Months Ended June 30, 2026 | — |
| Specialty Property & Casualty Insurance Gross Premiums Written | $198.42M | Six Months Ended June 30, 2026 | — |
| Specialty Property and Casualty Insurance EBITDA | $1.24M | Three Months Ended June 30, 2026 filing | — |
| Total Organic Revenue & Growth Percentage | $95M | Six Months Ended June 30, 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
OSG
this stock
Octave Specialty Group Inc
|
$240.63M | -31.4% | +6.5% | — | 3.3% |
|
FNF
Fidelity National Financial, Inc.
|
$11.64B | -20.5% | +5.6% | 11.1 | 4.5% |
|
AXS
Axis Capital Holdings Ltd
|
$7.80B | +1.5% | +10.2% | 8.3 | 3.0% |
|
FAF
First American Financial Corp
|
$6.62B | +5.6% | +21.6% | 9.2 | 5.9% |
|
ACT
Enact Holdings, Inc.
|
$6.10B | +14.5% | +2.8% | 9.4 | 2.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
Octave Specialty Group, Inc. reported third-quarter revenue of $85.3 million, up 28%, and adjusted EBITDA to shareholders of $3.3 million versus $(2.9) million, while the loss attributable to shareholders narrowed to $(13.8) million.
View| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| OSG | +7.0% | +14.6% | -3.6% | +6.0% | -31.4% |
| SPY | +2.6% | -1.2% | +0.5% | -0.2% | +10.6% |
| vs SPY | +4.4% | +15.8% | -4.1% | +6.1% | -42.0% |
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.
